Krishna Institute of Medical Sciences Limited (KIMS) has filed a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulation 30 regarding the acquisition of a majority stake in Sarvottam Health Care Private Limited.

Transaction Details

  • Target Entity: Sarvottam Health Care Private Limited, Kakinada
  • Stake Acquired: 51% of total paid-up equity share capital
  • Number of Shares: 21,72,713 equity shares of ₹10 each
  • Consideration: Aggregate consideration of up to ₹79.50 crore (Rupees Seventy Nine Crore Fifty Lakhs only)
  • Payment Method: Cash consideration
  • Valuation Basis: Valuation report issued by BDO Valuation Advisory LLP dated 5th October, 2026
  • Current Status: Consideration has been remitted by KIMS. Share transfer will be completed in due course.

Target Company Background

Sarvottam Health Care Private Limited operates under the brand name "Trust Multi Speciality Hospital" in Kakinada:

  • Date of Incorporation: 19 April 2011
  • Initial Capacity: 50 beds (commenced operations in 2010)
  • Current Capacity: 183 beds
  • Facility: State-of-the-art hospital campus with cellar + ground floor + 7 upper floors (G+7 structure)
  • Built-up Area: Approximately 9,847.23 square meters
  • Land Ownership: Company-owned land measuring 3,001.36 square yards
  • Location: Kakinada, Andhra Pradesh, India

Financial Performance of Target Company

| Financial Year | Turnover (₹ Crore) |

| FY 2023-24 | 74.36 |

| FY 2024-25 | 81.38 |

| FY 2025-26 | 84.83 |

Additional FY 2025-26 Metrics:

  • PAT: ₹7.06 crore
  • Networth: ₹50.30 crore

Strategic Rationale

The acquisition represents a strategic investment by KIMS, which already serves as the Operation and Management (O&M) service provider to Sarvottam Health Care Private Limited. The investment is made by virtue of a call option agreement with the target entity.

Regulatory and Compliance Aspects

  • Related Party Transaction: The equity acquisition does not fall within the definition of Related Party Transaction
  • O&M Agreement: KIMS has entered into an Operation and Management agreement dated 10th September, 2026 with the target entity, provided on Arms Length basis
  • Government Approvals: Not applicable for this acquisition
  • Regulatory Reference: SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Timeline

The disclosure does not specify an indicative time period for completion of the acquisition, noting only that share transfer will be completed "in due course."

Additional Information

The intimation has been uploaded on the company's website at: https://www.kimshospitals.com/investors/ under Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30.